TRVI Stock: Price, Earnings History and SEC Filings
Trevi Therapeutics, Inc. (TRVI) last traded at $13.56, down 1.81% on the latest session and down 5.3% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.11 against an analyst estimate of $-0.11, a beat of 0.0%.
$13.56 -1.81%
1 month-5.31%
52-week high$20.22
52-week low$9.82
Volume1.73M
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
TRVI earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-0.11 | $-0.11 | +0.00% |
| Mar 2026 | May 5, 2026 | $-0.09 | $-0.07 | -28.57% |
| Dec 2025 | Mar 17, 2026 | $-0.06 | $-0.10 | +40.00% |
| Sep 2025 | Nov 13, 2025 | $-0.08 | $-0.10 | +20.00% |
TRVI beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for TRVI
SEC filing data is not available right now. You can search for TRVI on SEC EDGAR.
TRVI news
- Trevi Therapeutics (TRVI) Stock May Still Look Expensive Against Book ValueNov 1, 2026 · finance.yahoo.com
- Trevi Therapeutics to Participate in Stifel's 2026 Healthcare ConferenceOct 27, 2026 · finance.yahoo.com
About Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. (TRVI) is a US-listed public company on Nasdaq.